Amoebiasis historical perspective
Jump to navigation
Jump to search
Amoebiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Amoebiasis historical perspective On the Web |
American Roentgen Ray Society Images of Amoebiasis historical perspective |
Risk calculators and risk factors for Amoebiasis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
Amebiasis is thought to have been discovered by Hippocrates, who described a patient with fever and dysentery. In 1828, the association between dysentery and amebic liver abscess was reported by James Annesley, an Irish physician. In 1875, E. histolytica was first isolated from a patient with dysentery by Fedor Losch, a Russian physician.
Historical Perspective
- Amebiasis is thought to have been discovered by Hippocrates, who described a patient with fever and dysentery.[1]
- 1828 - The association between dysentery and amebic liver abscess was reported by James Annesley, an Irish physician.[2]
- 1875 - E. histolytica was first isolated from a patient with dysentery by Fedor Losch, a Russian physician.[2][3]
- 1903 - The organism was named Entamoeba histolytica by Fritz Schaudinn, a German zoologist.
- 1912 - Leonard Rogers, an English pathologist and tropical medicine specialist, described the efficacy of emetine (first treatment) for the treatment of amebiasis.[4]
- 1925 - The life cycle of E. histolytica was first described by Clifford Dobell, an English protozoologist.[5]
References
- ↑ Tanyuksel M, Petri WA (2003). "Laboratory diagnosis of amebiasis". Clin Microbiol Rev. 16 (4): 713–29. PMC 207118. PMID 14557296.
- ↑ 2.0 2.1 Ravdin, J. I. (1988). A history of amebiasis - Amebiasis: human infection by Entamoeba histolytica. New York, N.Y.: John Wiley & Sons, Inc. p. 1-10.
- ↑ STILWELL GG (1955). "Amebiasis: its early history". Gastroenterology. 28 (4): 606–22. PMID 14366122.
- ↑ Rogers L (1912). "THE RAPID CURE OF AMOEBIC DYSENTERY AND HEPATITIS BY HYPODERMIC INJECTIONS OF SOLUBLE SALTS OF EMETINE". Br Med J. 1 (2686): 1424–5. PMC 2345206. PMID 20766221.
- ↑ Brumpt, E (1925). "Étude sommaire de l' "Entamoeba dispar" n. sp. Amibe à kystes quadrinuclées, parasite de l'homme". Bull. Acad. Med. (Paris). 94: 943–952.
|access-date=
requires|url=
(help)